Baird Medical Investment Holdings Limited (BDMD)

BDMD Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	33.05	31.46	35.09	188.66	118.29	85.03
Revenue Growth (YoY)	-82.48%	-10.35%	-81.40%	59.50%	39.11%	-
Cost of Revenue	3.83	4.23	7.05	31.92	16.39	9.04
Gross Profit	29.22	27.23	28.04	156.74	101.9	75.99
Selling, General & Admin	11.25	11.09	10.55	54.87	30.03	27.82
Research & Development	4.02	4.27	3.86	9.77	4.9	8.05
Other Operating Expenses	-	-	-	1.98	1.24	0.79
Operating Expenses	15.26	15.37	14.41	63.99	38.76	37.72
Operating Income	13.96	11.86	13.63	92.75	63.14	38.27
Interest Expense	-0.44	-0.29	-0.3	-0.98	-1.05	-0.65
Interest & Investment Income	0	0	0.01	0.02	0.01	0.02
Currency Exchange Gain (Loss)	-	-	-	0.33	-	-
Other Non Operating Income (Expenses)	0.76	0.78	1.18	0.9	-24.62	-79.92
EBT Excluding Unusual Items	14.28	12.36	14.52	93.01	37.48	-42.28
Other Unusual Items	-	-	-	-2.07	25.05	1.56
Pretax Income	14.28	12.36	14.52	90.94	62.53	-40.72
Income Tax Expense	1.6	1.7	1.75	16.08	15.84	8.94
Earnings From Continuing Operations	12.68	10.66	12.77	74.86	46.69	-49.66
Minority Interest in Earnings	-0.13	-0.11	-0.21	-0.65	-0.34	-0.36
Net Income	12.55	10.55	12.57	74.21	46.35	-50.02
Net Income to Common	12.55	10.55	12.57	74.21	46.35	-50.02
Net Income Growth	-83.09%	-16.09%	-83.06%	60.10%	-	-
Shares Outstanding (Basic)	29	29	29	1,181	-	-
Shares Outstanding (Diluted)	29	29	29	1,181	-	-
Shares Change (YoY)	-97.51%	-	-97.51%	-	-	-
EPS (Basic)	0.43	0.36	0.43	0.06	-	-
EPS (Diluted)	0.43	0.36	0.43	0.06	-	-
EPS Growth	578.78%	-16.09%	580.02%	-	-	-
Free Cash Flow	-7.48	-3.66	-5.42	37.64	21.23	23.86
Free Cash Flow Per Share	-0.25	-0.12	-0.18	0.03	-	-
Gross Margin	88.41%	86.56%	79.90%	83.08%	86.14%	89.37%
Operating Margin	42.23%	37.71%	38.85%	49.16%	53.38%	45.01%
Profit Margin	37.96%	33.52%	35.82%	39.33%	39.18%	-58.83%
Free Cash Flow Margin	-22.64%	-11.63%	-15.45%	19.95%	17.94%	28.06%
EBITDA	15.13	12.85	14.49	97.93	67.12	40.7
EBITDA Margin	45.78%	40.86%	41.30%	51.91%	56.74%	47.87%
D&A For EBITDA	1.17	0.99	0.86	5.18	3.98	2.43
EBIT	13.96	11.86	13.63	92.75	63.14	38.27
EBIT Margin	42.23%	37.71%	38.85%	49.16%	53.38%	45.01%
Effective Tax Rate	11.21%	13.76%	12.03%	17.69%	25.32%	-

Source: S&P Capital IQ. Standard template. Financial Sources.